Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana 25th Annual Meeting of the American-Gynecological-and-Obstetrical-Society Blumenthal, P. D., Gaffikin, L., Deganus, S., Lewis, R., Emerson, M., Adadevoh, S. MOSBY-ELSEVIER. 2007

Abstract

The purpose of this study was to assess the safety and acceptability of a single-visit approach to cervical cancer prevention combining visual inspection of the cervix with acetic acid wash (VIA) and cryotherapy.The study was observational. Nine clinicians were trained in VIA and cryotherapy. Over 18 months 3665 women were VIA-tested. If positive and eligible, cryotherapy was offered immediately. Treated women were followed-up at 3 months and 1 year.The test-positive rate was 13.2%. Of those eligible, 70.2% and 21% received immediate or delayed treatment, respectively. No major complications were recorded, and 5.6% presented for a perceived problem post-cryotherapy. Among those treated over 90% expressed satisfaction with their experience, and 96% had an indentifiable squamo-columnar junction. Only 2.6% (6/232) were test positive, 1-year posttreatment.A single-visit approach using VIA and cryotherapy proved to be safe, acceptable, and feasible in an urban African setting.

View details for DOI 10.1016/j.ajog.2006.12.031

View details for Web of Science ID 000245747600053

View details for PubMedID 17403438